CD4 and neoplasm: In a second study, Galaine et al. reported the presence of anti-tumour CD4+ T cells that recognised MHC II-restricted, promiscuously-binding tumour-associated antigens in colorectal cancer patients undergoing oxaliplatin chemotherapy.